Astera Labs, Inc.
ALAB
$320.17
-$1.44-0.45%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 104.45% | 93.40% | 91.77% | 103.89% | 149.74% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 104.45% | 93.40% | 91.77% | 103.89% | 149.74% |
| Cost of Revenue | 126.12% | 82.91% | 80.39% | 117.24% | 172.78% |
| Gross Profit | 97.56% | 96.92% | 95.77% | 100.07% | 143.20% |
| SG&A Expenses | 59.79% | 9.41% | -8.49% | -10.05% | -11.44% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 99.24% | 66.40% | 44.46% | 43.60% | 50.35% |
| Operating Income | 124.39% | 447.92% | 46,398.61% | 722.82% | 263.36% |
| Income Before Tax | 102.97% | 238.05% | 637.39% | 3,216.57% | 459.72% |
| Income Tax Expenses | -8,875.54% | 31.74% | 342.19% | -352.39% | 91.43% |
| Earnings from Continuing Operations | 198.89% | 152.40% | 82.02% | 1,299.97% | 778.76% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 198.89% | 152.40% | 82.02% | 1,299.97% | 778.76% |
| EBIT | 124.39% | 447.92% | 46,398.61% | 722.82% | 263.36% |
| EBITDA | 126.34% | 428.15% | 6,143.65% | 806.75% | 274.21% |
| EPS Basic | 186.85% | 141.23% | 71.67% | 1,224.38% | 737.04% |
| Normalized Basic EPS | 94.78% | 223.08% | 596.17% | 3,020.00% | 437.57% |
| EPS Diluted | 186.21% | 144.44% | 83.67% | 1,100.00% | 680.00% |
| Normalized Diluted EPS | 97.13% | 232.41% | 622.02% | 2,791.25% | 413.58% |
| Average Basic Shares Outstanding | 4.20% | 4.62% | 6.01% | 6.76% | 6.59% |
| Average Diluted Shares Outstanding | 2.94% | 1.71% | 2.04% | 15.18% | 14.76% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |